Нарушения мозгового кровообращения: литература
Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81, 1994
Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449, 1994 (Erratum: ibid, p 2254)
Easton JD, Wilterdink JL: Carotid endarterectomy: Trials and tribulations. Ann Neurol 35:5, 1994
European Carotid Surgery Trialists' Collaborative Group: MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337:1235, 1991
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421, 1995
Moore WS et al: Guidelines for carotid endarterectomy: A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Stroke 26:188, 1995
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445, 1991
Stroke Prevention in Atrial Fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343:687, 1994
The European Atrial Fibrillation Trial Study Group: Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med 333:5, 1995
The National Institute of Neurological Disorders and Stroke rt-Pa Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581, 1995
van Gijn J et al: Major ongoing stroke trials: Anticoagulants versus aspirin in patients with transient ischemic attacks or nondisabling ischemic stroke: SPIRIT (Stroke Prevention In Reversible Ischemia Trial) Stroke 26:1140, 1995
Wilterdink JL, Easton JD: Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol 49:857, 1992
